

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | retina homeostasis (GO:0001895) | 9.61203803 |
| 2 | humoral immune response (GO:0006959) | 8.49673097 |
| 3 | interferon-gamma secretion (GO:0072643) | 6.63351063 |
| 4 | regulation of regulatory T cell differentiation (GO:0045589) | 6.43426424 |
| 5 | epithelial cell differentiation involved in kidney development (GO:0035850) | 6.06770478 |
| 6 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 5.98566384 |
| 7 | glomerular filtration (GO:0003094) | 5.85434895 |
| 8 | mature B cell differentiation involved in immune response (GO:0002313) | 5.82660516 |
| 9 | negative regulation of B cell proliferation (GO:0030889) | 5.78669081 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.74312965 |
| 11 | positive regulation of B cell differentiation (GO:0045579) | 5.71793899 |
| 12 | negative regulation of glucose import (GO:0046325) | 5.62968262 |
| 13 | B cell receptor signaling pathway (GO:0050853) | 5.51651146 |
| 14 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 5.30457273 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.27872639 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.27872639 |
| 17 | signal peptide processing (GO:0006465) | 5.27476427 |
| 18 | regulation of T cell tolerance induction (GO:0002664) | 5.26428407 |
| 19 | positive regulation of tolerance induction (GO:0002645) | 5.21306998 |
| 20 | renal filtration (GO:0097205) | 5.12326218 |
| 21 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.98907950 |
| 22 | regulation of B cell differentiation (GO:0045577) | 4.81532087 |
| 23 | L-fucose catabolic process (GO:0042355) | 4.62399524 |
| 24 | fucose catabolic process (GO:0019317) | 4.62399524 |
| 25 | L-fucose metabolic process (GO:0042354) | 4.62399524 |
| 26 | regulation of tolerance induction (GO:0002643) | 4.58063770 |
| 27 | negative regulation of glucose transport (GO:0010829) | 4.57453865 |
| 28 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.47978477 |
| 29 | Fc-epsilon receptor signaling pathway (GO:0038095) | 4.47151744 |
| 30 | Fc receptor signaling pathway (GO:0038093) | 4.46483826 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.43714175 |
| 32 | cellular response to zinc ion (GO:0071294) | 4.41167048 |
| 33 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.40715833 |
| 34 | Peyers patch development (GO:0048541) | 4.40715833 |
| 35 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.37134413 |
| 36 | regulation of B cell proliferation (GO:0030888) | 4.28433912 |
| 37 | positive regulation of respiratory burst (GO:0060267) | 4.21284999 |
| 38 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 4.11711895 |
| 39 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.10079158 |
| 40 | response to protozoan (GO:0001562) | 4.09055237 |
| 41 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.99589448 |
| 42 | amyloid precursor protein catabolic process (GO:0042987) | 3.98748504 |
| 43 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.95772233 |
| 44 | immune response-activating signal transduction (GO:0002757) | 3.88402050 |
| 45 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.84970352 |
| 46 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.75497719 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.73941026 |
| 48 | definitive hemopoiesis (GO:0060216) | 3.70230696 |
| 49 | regulation of respiratory burst (GO:0060263) | 3.68805859 |
| 50 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.62819196 |
| 51 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.60057188 |
| 52 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.57300956 |
| 53 | activation of immune response (GO:0002253) | 3.50977388 |
| 54 | detection of bacterium (GO:0016045) | 3.49244470 |
| 55 | T-helper 1 type immune response (GO:0042088) | 3.39343799 |
| 56 | phenylpropanoid metabolic process (GO:0009698) | 3.39160011 |
| 57 | type I interferon signaling pathway (GO:0060337) | 3.37835365 |
| 58 | cellular response to type I interferon (GO:0071357) | 3.37835365 |
| 59 | angiogenesis involved in wound healing (GO:0060055) | 3.36116980 |
| 60 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.36018071 |
| 61 | positive regulation of immunoglobulin production (GO:0002639) | 3.34941104 |
| 62 | immunoglobulin mediated immune response (GO:0016064) | 3.34148734 |
| 63 | response to type I interferon (GO:0034340) | 3.34023342 |
| 64 | detection of other organism (GO:0098543) | 3.33454006 |
| 65 | negative regulation of B cell apoptotic process (GO:0002903) | 3.33362409 |
| 66 | regulation of germinal center formation (GO:0002634) | 3.32791766 |
| 67 | positive regulation of T cell mediated immunity (GO:0002711) | 3.31951299 |
| 68 | germinal center formation (GO:0002467) | 3.26970499 |
| 69 | negative thymic T cell selection (GO:0045060) | 3.24035279 |
| 70 | gland morphogenesis (GO:0022612) | 3.17230470 |
| 71 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.16156455 |
| 72 | endothelium development (GO:0003158) | 3.15743273 |
| 73 | cellular response to antibiotic (GO:0071236) | 3.15544805 |
| 74 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.13617704 |
| 75 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.13092529 |
| 76 | B cell proliferation (GO:0042100) | 3.10476102 |
| 77 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.09736650 |
| 78 | peptidyl-asparagine modification (GO:0018196) | 3.08949813 |
| 79 | regulation of antigen processing and presentation (GO:0002577) | 3.06604296 |
| 80 | regulation of B cell activation (GO:0050864) | 3.05677664 |
| 81 | negative regulation of B cell activation (GO:0050869) | 3.02290992 |
| 82 | membrane protein ectodomain proteolysis (GO:0006509) | 3.01867390 |
| 83 | sleep (GO:0030431) | 3.01305026 |
| 84 | antibacterial humoral response (GO:0019731) | 3.00047557 |
| 85 | complement activation, classical pathway (GO:0006958) | 23.9255540 |
| 86 | positive regulation of cell killing (GO:0031343) | 2.98153273 |
| 87 | negative T cell selection (GO:0043383) | 2.94232260 |
| 88 | positive regulation of antigen processing and presentation (GO:0002579) | 2.92521924 |
| 89 | maternal placenta development (GO:0001893) | 2.92286898 |
| 90 | positive regulation of Rap GTPase activity (GO:0032854) | 2.91418496 |
| 91 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.90333953 |
| 92 | Golgi transport vesicle coating (GO:0048200) | 2.88721126 |
| 93 | COPI coating of Golgi vesicle (GO:0048205) | 2.88721126 |
| 94 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.88430106 |
| 95 | positive regulation of nuclease activity (GO:0032075) | 2.88169381 |
| 96 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.87837179 |
| 97 | protein N-linked glycosylation (GO:0006487) | 2.87376296 |
| 98 | histamine secretion (GO:0001821) | 2.84244372 |
| 99 | antimicrobial humoral response (GO:0019730) | 2.84160300 |
| 100 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.82914937 |
| 101 | negative regulation of bone remodeling (GO:0046851) | 2.82465033 |
| 102 | negative regulation of bone resorption (GO:0045779) | 2.81795512 |
| 103 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.78518272 |
| 104 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.78169480 |
| 105 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.77406525 |
| 106 | mannose metabolic process (GO:0006013) | 2.77094069 |
| 107 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.76879828 |
| 108 | amyloid precursor protein metabolic process (GO:0042982) | 2.76861566 |
| 109 | B cell mediated immunity (GO:0019724) | 2.76176089 |
| 110 | bone trabecula formation (GO:0060346) | 2.75309160 |
| 111 | regulation of nuclease activity (GO:0032069) | 2.74643483 |
| 112 | N-glycan processing (GO:0006491) | 2.73569845 |
| 113 | B cell homeostasis (GO:0001782) | 2.73036091 |
| 114 | mature B cell differentiation (GO:0002335) | 2.72789027 |
| 115 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.71953600 |
| 116 | histone H3-K36 demethylation (GO:0070544) | 2.71609639 |
| 117 | cellular response to unfolded protein (GO:0034620) | 2.70425405 |
| 118 | N-acetylneuraminate metabolic process (GO:0006054) | 2.68811713 |
| 119 | proline biosynthetic process (GO:0006561) | 2.68703093 |
| 120 | positive regulation of lamellipodium assembly (GO:0010592) | 2.67377929 |
| 121 | rRNA catabolic process (GO:0016075) | 2.67181978 |
| 122 | cellular response to interferon-gamma (GO:0071346) | 2.67001992 |
| 123 | tissue homeostasis (GO:0001894) | 2.66883072 |
| 124 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.66536102 |
| 125 | respiratory burst (GO:0045730) | 2.66167231 |
| 126 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.65446314 |
| 127 | response to host immune response (GO:0052572) | 2.65446314 |
| 128 | pinocytosis (GO:0006907) | 2.65350130 |
| 129 | regulation of gamma-delta T cell activation (GO:0046643) | 2.65086040 |
| 130 | thymic T cell selection (GO:0045061) | 2.64758506 |
| 131 | negative regulation of osteoclast differentiation (GO:0045671) | 2.62870130 |
| 132 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.62161636 |
| 133 | negative regulation of phagocytosis (GO:0050765) | 2.61538395 |
| 134 | pyrimidine dimer repair (GO:0006290) | 2.60869033 |
| 135 | positive T cell selection (GO:0043368) | 2.59314298 |
| 136 | bone resorption (GO:0045453) | 2.58420883 |
| 137 | regulation of B cell apoptotic process (GO:0002902) | 2.58269157 |
| 138 | cellular hyperosmotic response (GO:0071474) | 2.56544799 |
| 139 | purine nucleotide salvage (GO:0032261) | 2.55979744 |
| 140 | regulation of T cell mediated immunity (GO:0002709) | 2.55812259 |
| 141 | prostaglandin biosynthetic process (GO:0001516) | 2.52725439 |
| 142 | prostanoid biosynthetic process (GO:0046457) | 2.52725439 |
| 143 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.51582698 |
| 144 | mast cell activation (GO:0045576) | 2.50581027 |
| 145 | seminiferous tubule development (GO:0072520) | 2.50058128 |
| 146 | regulation of superoxide anion generation (GO:0032928) | 2.49857067 |
| 147 | detection of external biotic stimulus (GO:0098581) | 2.49788849 |
| 148 | dosage compensation (GO:0007549) | 2.48876110 |
| 149 | response to interferon-beta (GO:0035456) | 2.48833845 |
| 150 | positive regulation of B cell activation (GO:0050871) | 2.48293406 |
| 151 | positive regulation of histone deacetylation (GO:0031065) | 2.47866997 |
| 152 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.47451201 |
| 153 | intestinal epithelial cell development (GO:0060576) | 2.47266592 |
| 154 | lymph node development (GO:0048535) | 2.46828154 |
| 155 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.46513742 |
| 156 | regulation of cell killing (GO:0031341) | 2.45500722 |
| 157 | ER-nucleus signaling pathway (GO:0006984) | 2.44930661 |
| 158 | cellular response to topologically incorrect protein (GO:0035967) | 2.44376280 |
| 159 | regulation of Rap GTPase activity (GO:0032317) | 2.44311820 |
| 160 | defense response to Gram-negative bacterium (GO:0050829) | 2.44103979 |
| 161 | T cell selection (GO:0045058) | 2.42210108 |
| 162 | positive thymic T cell selection (GO:0045059) | 2.40900113 |
| 163 | regulation of immunoglobulin production (GO:0002637) | 2.40285696 |
| 164 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.40242198 |
| 165 | B cell activation (GO:0042113) | 2.39761017 |
| 166 | serine transport (GO:0032329) | 2.38924912 |
| 167 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.36132343 |
| 168 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 2.34626673 |
| 169 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.34192448 |
| 170 | negative regulation of cell killing (GO:0031342) | 2.34192448 |
| 171 | complement activation (GO:0006956) | 18.3340266 |
| 172 | protein activation cascade (GO:0072376) | 11.8668680 |
| 173 | Fc-gamma receptor signaling pathway (GO:0038094) | 10.6074473 |
| 174 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 10.6074473 |
| 175 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 10.6074473 |
| 176 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 10.4727253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.37782752 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.18797401 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.11640381 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.80020787 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.52265181 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.45861275 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 4.24465109 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.22719511 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.17846979 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.95142023 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.82718690 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.60825839 |
| 13 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.27204124 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.24497567 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.92268986 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.79932782 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.76248252 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.75379874 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.65985394 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.47219240 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.35746424 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.34759566 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.34062971 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.33368480 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.30404431 |
| 26 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.27446776 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.20780611 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.10575773 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10311912 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.09628132 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06955053 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.06923440 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 2.05271943 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.03458443 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.98716861 |
| 36 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.98638671 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97362812 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97281696 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.91424179 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.90613852 |
| 41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.89154847 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.86586728 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.75021282 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.73048935 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.67489118 |
| 46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66697997 |
| 47 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.63299628 |
| 48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.62675968 |
| 49 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.62420146 |
| 50 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.61246033 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.59598246 |
| 52 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.59312333 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56539092 |
| 54 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.56238268 |
| 55 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55819502 |
| 56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55647437 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53646532 |
| 58 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.52954050 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.49420054 |
| 60 | GATA3_26560356_Chip-Seq_TH2_Human | 1.49175172 |
| 61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.48121153 |
| 62 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.42742288 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41169097 |
| 64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41159487 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33785311 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32883385 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 1.31623609 |
| 68 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31474531 |
| 69 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.21890743 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21162861 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21160002 |
| 72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15640775 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15611890 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15414234 |
| 75 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.14872669 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14565186 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12501331 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11922452 |
| 79 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11610887 |
| 80 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09268259 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08894276 |
| 82 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08180657 |
| 83 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06879698 |
| 84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04016429 |
| 85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01999393 |
| 86 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.00952651 |
| 87 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.00329769 |
| 88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00182420 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99720509 |
| 90 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99685484 |
| 91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99421580 |
| 92 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.98559874 |
| 93 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.97536870 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95808224 |
| 95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95712497 |
| 96 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.95412160 |
| 97 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.92680136 |
| 98 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.92054844 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92051925 |
| 100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90760490 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89724013 |
| 102 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89552756 |
| 103 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89174008 |
| 104 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.87502840 |
| 105 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86324222 |
| 106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85929266 |
| 107 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.85325630 |
| 108 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.85223371 |
| 109 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.84372196 |
| 110 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.83923351 |
| 111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83080553 |
| 112 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.81650772 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81476271 |
| 114 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.81407714 |
| 115 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.81273804 |
| 116 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.80421016 |
| 117 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.80326321 |
| 118 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.78638286 |
| 119 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.78039993 |
| 120 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.77696893 |
| 121 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77472311 |
| 122 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.76551511 |
| 123 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75796318 |
| 124 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.75568106 |
| 125 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.74990966 |
| 126 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.74880612 |
| 127 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74133330 |
| 128 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74047554 |
| 129 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.74023023 |
| 130 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73712018 |
| 131 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73374006 |
| 132 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72458443 |
| 133 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.71470289 |
| 134 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.71470289 |
| 135 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.71107197 |
| 136 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69522803 |
| 137 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68795887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.33231557 |
| 2 | MP0001800_abnormal_humoral_immune | 4.70362730 |
| 3 | MP0003303_peritoneal_inflammation | 4.29539826 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.78514566 |
| 5 | MP0001790_abnormal_immune_system | 3.46401940 |
| 6 | MP0005387_immune_system_phenotype | 3.46401940 |
| 7 | MP0002452_abnormal_antigen_presenting | 3.44164516 |
| 8 | MP0005671_abnormal_response_to | 3.27833084 |
| 9 | MP0002723_abnormal_immune_serum | 2.95074329 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.83569216 |
| 11 | MP0002398_abnormal_bone_marrow | 2.82318996 |
| 12 | MP0001819_abnormal_immune_cell | 2.78657206 |
| 13 | MP0000716_abnormal_immune_system | 2.66821289 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.61942280 |
| 15 | MP0000685_abnormal_immune_system | 2.59060777 |
| 16 | MP0006054_spinal_hemorrhage | 2.56503535 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.47121477 |
| 18 | MP0002396_abnormal_hematopoietic_system | 2.44569902 |
| 19 | MP0000689_abnormal_spleen_morphology | 2.38591660 |
| 20 | MP0001879_abnormal_lymphatic_vessel | 2.27754550 |
| 21 | MP0009697_abnormal_copulation | 2.24634077 |
| 22 | MP0005025_abnormal_response_to | 2.20328381 |
| 23 | MP0002429_abnormal_blood_cell | 2.20135314 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.11158402 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.06705440 |
| 26 | MP0002722_abnormal_immune_system | 1.99165946 |
| 27 | MP0002419_abnormal_innate_immunity | 1.98601950 |
| 28 | MP0003436_decreased_susceptibility_to | 1.98167007 |
| 29 | MP0003279_aneurysm | 1.95048554 |
| 30 | MP0000465_gastrointestinal_hemorrhage | 1.93129856 |
| 31 | MP0004264_abnormal_extraembryonic_tissu | 1.86893209 |
| 32 | MP0002006_tumorigenesis | 1.85431100 |
| 33 | MP0004147_increased_porphyrin_level | 1.82658174 |
| 34 | MP0005275_abnormal_skin_tensile | 1.79966359 |
| 35 | MP0004947_skin_inflammation | 1.79833117 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.76656120 |
| 37 | MP0010234_abnormal_vibrissa_follicle | 1.76490857 |
| 38 | MP0002282_abnormal_trachea_morphology | 1.73814818 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.73026423 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.72875634 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.62843326 |
| 42 | MP0000858_altered_metastatic_potential | 1.61180323 |
| 43 | MP0002405_respiratory_system_inflammati | 1.53761522 |
| 44 | MP0009278_abnormal_bone_marrow | 1.51835478 |
| 45 | MP0003448_altered_tumor_morphology | 1.45956819 |
| 46 | MP0009785_altered_susceptibility_to | 1.44107416 |
| 47 | MP0000566_synostosis | 1.38358849 |
| 48 | MP0000377_abnormal_hair_follicle | 1.36165926 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.36148052 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.35609016 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.33881594 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.33801078 |
| 53 | MP0008057_abnormal_DNA_replication | 1.32535769 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.30941870 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.30941870 |
| 56 | MP0003045_fibrosis | 1.28219221 |
| 57 | MP0004134_abnormal_chest_morphology | 1.24392307 |
| 58 | MP0005075_abnormal_melanosome_morpholog | 1.21777477 |
| 59 | MP0002019_abnormal_tumor_incidence | 1.20320929 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.20289332 |
| 61 | MP0002796_impaired_skin_barrier | 1.19511854 |
| 62 | MP0006082_CNS_inflammation | 1.18670873 |
| 63 | MP0004782_abnormal_surfactant_physiolog | 1.17698614 |
| 64 | MP0003868_abnormal_feces_composition | 1.15747930 |
| 65 | MP0001666_abnormal_nutrient_absorption | 1.14718749 |
| 66 | MP0003866_abnormal_defecation | 1.14455199 |
| 67 | MP0001881_abnormal_mammary_gland | 1.13857736 |
| 68 | MP0005310_abnormal_salivary_gland | 1.12634123 |
| 69 | MP0003941_abnormal_skin_development | 1.11190120 |
| 70 | MP0002933_joint_inflammation | 1.10601547 |
| 71 | MP0002234_abnormal_pharynx_morphology | 1.10546683 |
| 72 | MP0002098_abnormal_vibrissa_morphology | 1.09441775 |
| 73 | MP0001853_heart_inflammation | 1.08996536 |
| 74 | MP0000490_abnormal_crypts_of | 1.05546421 |
| 75 | MP0000920_abnormal_myelination | 1.04966664 |
| 76 | MP0005360_urolithiasis | 1.04825657 |
| 77 | MP0005623_abnormal_meninges_morphology | 1.04633962 |
| 78 | MP0002139_abnormal_hepatobiliary_system | 1.04230585 |
| 79 | MP0005076_abnormal_cell_differentiation | 1.02079084 |
| 80 | MP0003828_pulmonary_edema | 1.01611052 |
| 81 | MP0002060_abnormal_skin_morphology | 1.00258579 |
| 82 | MP0010678_abnormal_skin_adnexa | 1.00202675 |
| 83 | MP0008961_abnormal_basal_metabolism | 0.99369123 |
| 84 | MP0002876_abnormal_thyroid_physiology | 0.97799580 |
| 85 | MP0001873_stomach_inflammation | 0.96779568 |
| 86 | MP0000613_abnormal_salivary_gland | 0.96721275 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.96377986 |
| 88 | MP0008569_lethality_at_weaning | 0.95981875 |
| 89 | MP0004185_abnormal_adipocyte_glucose | 0.95598611 |
| 90 | MP0005166_decreased_susceptibility_to | 0.95292395 |
| 91 | MP0009840_abnormal_foam_cell | 0.94759694 |
| 92 | MP0000383_abnormal_hair_follicle | 0.93310444 |
| 93 | MP0000762_abnormal_tongue_morphology | 0.91113106 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.90981616 |
| 95 | MP0008872_abnormal_physiological_respon | 0.90757085 |
| 96 | MP0005165_increased_susceptibility_to | 0.90587499 |
| 97 | MP0004858_abnormal_nervous_system | 0.88125402 |
| 98 | MP0003795_abnormal_bone_structure | 0.87342328 |
| 99 | MP0000627_abnormal_mammary_gland | 0.86990831 |
| 100 | MP0008469_abnormal_protein_level | 0.85835662 |
| 101 | MP0005164_abnormal_response_to | 0.82572173 |
| 102 | MP0010386_abnormal_urinary_bladder | 0.81805480 |
| 103 | MP0000343_altered_response_to | 0.81687388 |
| 104 | MP0002877_abnormal_melanocyte_morpholog | 0.80687816 |
| 105 | MP0004381_abnormal_hair_follicle | 0.79052434 |
| 106 | MP0001851_eye_inflammation | 0.78781309 |
| 107 | MP0001919_abnormal_reproductive_system | 0.77322669 |
| 108 | MP0001663_abnormal_digestive_system | 0.77151119 |
| 109 | MP0005390_skeleton_phenotype | 0.77089241 |
| 110 | MP0001533_abnormal_skeleton_physiology | 0.76298605 |
| 111 | MP0000609_abnormal_liver_physiology | 0.76079668 |
| 112 | MP0004510_myositis | 0.75804854 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.74876681 |
| 114 | MP0003075_altered_response_to | 0.73564791 |
| 115 | MP0003690_abnormal_glial_cell | 0.71412709 |
| 116 | MP0001664_abnormal_digestion | 0.70564209 |
| 117 | MP0000003_abnormal_adipose_tissue | 0.69468030 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68068353 |
| 119 | MP0005388_respiratory_system_phenotype | 0.66882293 |
| 120 | MP0002133_abnormal_respiratory_system | 0.66882293 |
| 121 | MP0000733_abnormal_muscle_development | 0.66072524 |
| 122 | MP0009046_muscle_twitch | 0.64685460 |
| 123 | MP0002083_premature_death | 0.64348127 |
| 124 | MP0005085_abnormal_gallbladder_physiolo | 0.60909982 |
| 125 | MP0008873_increased_physiological_sensi | 0.60438300 |
| 126 | MP0009643_abnormal_urine_homeostasis | 0.60326469 |
| 127 | MP0003724_increased_susceptibility_to | 0.59584132 |
| 128 | MP0003186_abnormal_redox_activity | 0.59484620 |
| 129 | MP0002693_abnormal_pancreas_physiology | 0.58321160 |
| 130 | MP0003566_abnormal_cell_adhesion | 0.58255037 |
| 131 | MP0002168_other_aberrant_phenotype | 0.55675155 |
| 132 | MP0008874_decreased_physiological_sensi | 0.55186446 |
| 133 | MP0001191_abnormal_skin_condition | 0.54418582 |
| 134 | MP0005023_abnormal_wound_healing | 0.54266580 |
| 135 | MP0000013_abnormal_adipose_tissue | 0.53911940 |
| 136 | MP0002873_normal_phenotype | 0.52973140 |
| 137 | MP0002169_no_abnormal_phenotype | 0.52809517 |
| 138 | MP0005058_abnormal_lysosome_morphology | 0.51679128 |
| 139 | MP0010094_abnormal_chromosome_stability | 0.50554640 |
| 140 | MP0000598_abnormal_liver_morphology | 0.49988016 |
| 141 | MP0000477_abnormal_intestine_morphology | 0.49803564 |
| 142 | MP0001730_embryonic_growth_arrest | 0.49743771 |
| 143 | MP0000604_amyloidosis | 0.49312809 |
| 144 | MP0003183_abnormal_peptide_metabolism | 0.48821826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.06846633 |
| 2 | B lymphocytopenia (HP:0010976) | 8.54961154 |
| 3 | Abnormality of B cell number (HP:0010975) | 8.54961154 |
| 4 | Colitis (HP:0002583) | 6.51917494 |
| 5 | Recurrent sinusitis (HP:0011108) | 6.45871932 |
| 6 | Cellulitis (HP:0100658) | 6.37775387 |
| 7 | Recurrent bronchitis (HP:0002837) | 6.23099370 |
| 8 | Verrucae (HP:0200043) | 5.91641067 |
| 9 | Papilloma (HP:0012740) | 5.91641067 |
| 10 | Recurrent viral infections (HP:0004429) | 5.47842581 |
| 11 | IgM deficiency (HP:0002850) | 5.47528544 |
| 12 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 5.20674774 |
| 13 | Gastrointestinal stroma tumor (HP:0100723) | 4.89910632 |
| 14 | Meningitis (HP:0001287) | 4.84328190 |
| 15 | Inflammation of the large intestine (HP:0002037) | 4.80894220 |
| 16 | Flat capital femoral epiphysis (HP:0003370) | 4.78760826 |
| 17 | Gastrointestinal inflammation (HP:0004386) | 4.63971383 |
| 18 | Chronic otitis media (HP:0000389) | 4.39845507 |
| 19 | Recurrent pneumonia (HP:0006532) | 4.36401414 |
| 20 | Pili torti (HP:0003777) | 4.28310545 |
| 21 | Prostate neoplasm (HP:0100787) | 4.06596951 |
| 22 | Thyroiditis (HP:0100646) | 3.96347865 |
| 23 | Right ventricular cardiomyopathy (HP:0011663) | 3.94575658 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 3.82827810 |
| 25 | Osteomyelitis (HP:0002754) | 3.80237567 |
| 26 | Chronic sinusitis (HP:0011109) | 3.79385965 |
| 27 | Recurrent otitis media (HP:0000403) | 3.56322272 |
| 28 | Recurrent lower respiratory tract infections (HP:0002783) | 3.55573462 |
| 29 | Bronchitis (HP:0012387) | 3.48605261 |
| 30 | Cupped ribs (HP:0000887) | 3.37617877 |
| 31 | Sepsis (HP:0100806) | 3.37186260 |
| 32 | IgG deficiency (HP:0004315) | 3.28470802 |
| 33 | Abnormality of nail color (HP:0100643) | 3.27924817 |
| 34 | Abnormality of T cell physiology (HP:0011840) | 3.18587941 |
| 35 | Emphysema (HP:0002097) | 3.10904098 |
| 36 | Exostoses (HP:0100777) | 3.07010746 |
| 37 | IgA deficiency (HP:0002720) | 3.06640835 |
| 38 | Cone-rod dystrophy (HP:0000548) | 3.04246853 |
| 39 | Skin rash (HP:0000988) | 3.00561813 |
| 40 | Interstitial pulmonary disease (HP:0006530) | 2.96572347 |
| 41 | Sparse lateral eyebrow (HP:0005338) | 2.96395293 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.93218576 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.91942738 |
| 44 | Recurrent fungal infections (HP:0002841) | 2.89169091 |
| 45 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.88406285 |
| 46 | Vasculitis (HP:0002633) | 2.87178818 |
| 47 | Abnormality of T cells (HP:0002843) | 2.87060395 |
| 48 | Abnormality of the prostate (HP:0008775) | 2.84528517 |
| 49 | Alopecia of scalp (HP:0002293) | 2.80808947 |
| 50 | Flattened epiphyses (HP:0003071) | 2.72956086 |
| 51 | Abnormality of T cell number (HP:0011839) | 2.71263648 |
| 52 | Recurrent abscess formation (HP:0002722) | 2.69423246 |
| 53 | Radial bowing (HP:0002986) | 2.68742552 |
| 54 | Autoimmune hemolytic anemia (HP:0001890) | 2.64182241 |
| 55 | T lymphocytopenia (HP:0005403) | 2.63931871 |
| 56 | Restrictive lung disease (HP:0002091) | 2.61206479 |
| 57 | Recurrent bacterial skin infections (HP:0005406) | 2.58668158 |
| 58 | Lymphopenia (HP:0001888) | 2.57932445 |
| 59 | Deep philtrum (HP:0002002) | 2.54720694 |
| 60 | Cervical subluxation (HP:0003308) | 2.53052618 |
| 61 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.50291150 |
| 62 | Short nail (HP:0001799) | 2.49950282 |
| 63 | Flat acetabular roof (HP:0003180) | 2.48738077 |
| 64 | Nasal polyposis (HP:0100582) | 2.47743217 |
| 65 | Abnormality of macrophages (HP:0004311) | 2.46795490 |
| 66 | Abnormal hair laboratory examination (HP:0003328) | 2.46319443 |
| 67 | Distal lower limb amyotrophy (HP:0008944) | 2.45711975 |
| 68 | Hypoplasia of the thymus (HP:0000778) | 2.45494259 |
| 69 | Metaphyseal dysplasia (HP:0100255) | 2.42606575 |
| 70 | Metaphyseal cupping (HP:0003021) | 2.41360308 |
| 71 | Thoracic kyphosis (HP:0002942) | 2.37183976 |
| 72 | Mitral stenosis (HP:0001718) | 2.35396180 |
| 73 | Infantile muscular hypotonia (HP:0008947) | 2.34049314 |
| 74 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.33983286 |
| 75 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 2.33629238 |
| 76 | Stomach cancer (HP:0012126) | 2.33038726 |
| 77 | Abnormality of the epiphyses of the hand (HP:0005924) | 2.32774172 |
| 78 | Orchitis (HP:0100796) | 2.29173333 |
| 79 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.28978956 |
| 80 | Palpitations (HP:0001962) | 2.28929546 |
| 81 | Beaking of vertebral bodies (HP:0004568) | 2.27784036 |
| 82 | Myositis (HP:0100614) | 2.27141076 |
| 83 | Vertebral clefting (HP:0008428) | 2.24895534 |
| 84 | Recurrent skin infections (HP:0001581) | 2.24087843 |
| 85 | Skin ulcer (HP:0200042) | 2.23864046 |
| 86 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.23232767 |
| 87 | Osteolytic defects of the hand bones (HP:0009699) | 2.23232767 |
| 88 | Abnormal cartilage morphology (HP:0002763) | 2.22978771 |
| 89 | Flared iliac wings (HP:0002869) | 2.22213696 |
| 90 | Thrombocytosis (HP:0001894) | 2.20573414 |
| 91 | Acute myeloid leukemia (HP:0004808) | 2.19372692 |
| 92 | Abnormality of the nasal mucosa (HP:0000433) | 2.17374607 |
| 93 | Acute lymphatic leukemia (HP:0006721) | 2.15747992 |
| 94 | Combined immunodeficiency (HP:0005387) | 2.13478860 |
| 95 | Eosinophilia (HP:0001880) | 2.11140627 |
| 96 | Concave nail (HP:0001598) | 2.11028956 |
| 97 | Pulmonary infiltrates (HP:0002113) | 2.10672053 |
| 98 | Neutropenia (HP:0001875) | 2.09862532 |
| 99 | Curly hair (HP:0002212) | 2.08095777 |
| 100 | Severe combined immunodeficiency (HP:0004430) | 2.07965122 |
| 101 | Autoimmune thrombocytopenia (HP:0001973) | 2.06595024 |
| 102 | Dyschromatopsia (HP:0007641) | 2.04546064 |
| 103 | Mucosal telangiectasiae (HP:0100579) | 2.02384064 |
| 104 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.02173598 |
| 105 | Amyloidosis (HP:0011034) | 2.02072445 |
| 106 | Acrocyanosis (HP:0001063) | 1.97725274 |
| 107 | Bronchiectasis (HP:0002110) | 1.97003128 |
| 108 | Premature rupture of membranes (HP:0001788) | 1.96955008 |
| 109 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.96478326 |
| 110 | Abnormality of femoral epiphyses (HP:0006499) | 1.96478326 |
| 111 | Gastrointestinal infarctions (HP:0005244) | 1.95323002 |
| 112 | Urticaria (HP:0001025) | 1.94652024 |
| 113 | Vacuolated lymphocytes (HP:0001922) | 1.92807034 |
| 114 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.91214162 |
| 115 | Enlarged epiphyses (HP:0010580) | 1.90275601 |
| 116 | Papilledema (HP:0001085) | 1.88871946 |
| 117 | Lip pit (HP:0100267) | 1.88294438 |
| 118 | Irregular vertebral endplates (HP:0003301) | 1.86645233 |
| 119 | Abnormal auditory evoked potentials (HP:0006958) | 1.86454141 |
| 120 | Central scotoma (HP:0000603) | 1.86195735 |
| 121 | Spinal cord compression (HP:0002176) | 1.86167962 |
| 122 | Mediastinal lymphadenopathy (HP:0100721) | 1.86030332 |
| 123 | Bowed forearm bones (HP:0003956) | 1.86012306 |
| 124 | Bowing of the arm (HP:0006488) | 1.86012306 |
| 125 | Abnormality of complement system (HP:0005339) | 1.83411463 |
| 126 | Aortic dissection (HP:0002647) | 1.83212134 |
| 127 | Macroorchidism (HP:0000053) | 1.79255925 |
| 128 | Viral hepatitis (HP:0006562) | 1.79050272 |
| 129 | Small epiphyses (HP:0010585) | 1.78579705 |
| 130 | Increased IgE level (HP:0003212) | 1.76682732 |
| 131 | Lymphoma (HP:0002665) | 1.76290729 |
| 132 | Eczematoid dermatitis (HP:0000976) | 1.74197683 |
| 133 | Arthralgia (HP:0002829) | 1.73892469 |
| 134 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.71921431 |
| 135 | Recurrent cutaneous fungal infections (HP:0011370) | 1.71921431 |
| 136 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.69645050 |
| 137 | Obstructive lung disease (HP:0006536) | 1.69417418 |
| 138 | Chronic obstructive pulmonary disease (HP:0006510) | 1.69417418 |
| 139 | Abnormality of eosinophils (HP:0001879) | 1.68121232 |
| 140 | Leukopenia (HP:0001882) | 1.65367051 |
| 141 | Abnormal foot bone ossification (HP:0010675) | 1.63909336 |
| 142 | Abnormality of the fingertips (HP:0001211) | 1.62316667 |
| 143 | Conjunctival hamartoma (HP:0100780) | 1.59944689 |
| 144 | Xerostomia (HP:0000217) | 1.58517055 |
| 145 | Hypergammaglobulinemia (HP:0010702) | 1.54133187 |
| 146 | Granulocytopenia (HP:0001913) | 1.53973910 |
| 147 | Keratoconjunctivitis sicca (HP:0001097) | 1.53565618 |
| 148 | Abnormality of the intrinsic pathway (HP:0010989) | 1.53442268 |
| 149 | Teleangiectasia of the skin (HP:0100585) | 1.53398246 |
| 150 | Limb hypertonia (HP:0002509) | 1.50001861 |
| 151 | Abnormality of the lumbar spine (HP:0100712) | 1.48951259 |
| 152 | Leukocytosis (HP:0001974) | 1.48394682 |
| 153 | Encephalitis (HP:0002383) | 1.47449988 |
| 154 | Deep venous thrombosis (HP:0002625) | 1.46448855 |
| 155 | Spondylolisthesis (HP:0003302) | 1.45835662 |
| 156 | Keratoconjunctivitis (HP:0001096) | 1.45550573 |
| 157 | Periodontitis (HP:0000704) | 1.45299317 |
| 158 | Hypertensive crisis (HP:0100735) | 1.44161437 |
| 159 | Dehydration (HP:0001944) | 1.40214692 |
| 160 | Hypoproteinemia (HP:0003075) | 1.38904824 |
| 161 | Pustule (HP:0200039) | 1.36987573 |
| 162 | Pulmonary embolism (HP:0002204) | 1.36610778 |
| 163 | Abnormal platelet volume (HP:0011876) | 1.36496580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.84435073 |
| 2 | MAP4K1 | 5.13667839 |
| 3 | FLT3 | 3.91330702 |
| 4 | MAP4K2 | 3.73780154 |
| 5 | SCYL2 | 3.53679984 |
| 6 | KDR | 3.23704308 |
| 7 | GRK6 | 3.05639589 |
| 8 | RIPK4 | 2.85164381 |
| 9 | TAOK3 | 2.80054002 |
| 10 | MAP3K10 | 2.55235081 |
| 11 | TYK2 | 2.50705103 |
| 12 | SYK | 2.46685773 |
| 13 | CSF1R | 2.26496090 |
| 14 | KIT | 2.24131042 |
| 15 | SIK2 | 2.15755823 |
| 16 | TESK2 | 2.11719014 |
| 17 | BTK | 2.01067619 |
| 18 | NTRK1 | 1.86919228 |
| 19 | BMPR2 | 1.72573753 |
| 20 | MAP3K14 | 1.71455997 |
| 21 | BLK | 1.68986139 |
| 22 | IRAK4 | 1.66348933 |
| 23 | ITK | 1.66207748 |
| 24 | STK24 | 1.64554329 |
| 25 | STK10 | 1.62900159 |
| 26 | FGFR3 | 1.60966261 |
| 27 | MST1R | 1.59956039 |
| 28 | EIF2AK3 | 1.57148552 |
| 29 | TBK1 | 1.47234248 |
| 30 | JAK1 | 1.46874203 |
| 31 | EEF2K | 1.44192119 |
| 32 | LYN | 1.43780498 |
| 33 | MAP3K13 | 1.42429502 |
| 34 | MET | 1.37381188 |
| 35 | FES | 1.35492612 |
| 36 | STK38L | 1.34840903 |
| 37 | PIK3CG | 1.34796854 |
| 38 | CLK1 | 1.34472434 |
| 39 | PRKCH | 1.34002685 |
| 40 | NME2 | 1.32675676 |
| 41 | HCK | 1.31059019 |
| 42 | DMPK | 1.30746239 |
| 43 | JAK3 | 1.27724657 |
| 44 | HIPK2 | 1.26080222 |
| 45 | PIM1 | 1.26078374 |
| 46 | IRAK3 | 1.23060750 |
| 47 | NEK2 | 1.21068861 |
| 48 | LRRK2 | 1.15216813 |
| 49 | IKBKB | 1.10734430 |
| 50 | IKBKE | 1.08866151 |
| 51 | EPHA2 | 1.04763969 |
| 52 | FGFR4 | 1.03145158 |
| 53 | PIK3CA | 1.00112354 |
| 54 | TXK | 0.97305527 |
| 55 | PRKCQ | 0.96507012 |
| 56 | TESK1 | 0.94043383 |
| 57 | TGFBR2 | 0.93939546 |
| 58 | LCK | 0.92698411 |
| 59 | BCKDK | 0.91791398 |
| 60 | FRK | 0.91594471 |
| 61 | PBK | 0.90081218 |
| 62 | BMX | 0.89808476 |
| 63 | CDK12 | 0.89432638 |
| 64 | ALK | 0.88575870 |
| 65 | RPS6KA5 | 0.88120273 |
| 66 | TEC | 0.85682945 |
| 67 | RPS6KA4 | 0.85379254 |
| 68 | MAP3K6 | 0.83908274 |
| 69 | SIK1 | 0.79339203 |
| 70 | FGFR2 | 0.79158706 |
| 71 | MST4 | 0.78570455 |
| 72 | AKT3 | 0.78071659 |
| 73 | EPHA3 | 0.77352700 |
| 74 | DDR2 | 0.77305384 |
| 75 | IRAK1 | 0.76621319 |
| 76 | BUB1 | 0.73460985 |
| 77 | SRPK1 | 0.73011467 |
| 78 | IGF1R | 0.69357361 |
| 79 | MYLK | 0.68837555 |
| 80 | OXSR1 | 0.68585273 |
| 81 | SIK3 | 0.68353595 |
| 82 | PRKD1 | 0.67971607 |
| 83 | TAOK1 | 0.66770567 |
| 84 | CSK | 0.66461758 |
| 85 | SGK223 | 0.64596672 |
| 86 | SGK494 | 0.64596672 |
| 87 | MAPK4 | 0.62289593 |
| 88 | TTN | 0.61566476 |
| 89 | TRIB3 | 0.61300368 |
| 90 | MAPK7 | 0.60850750 |
| 91 | NEK9 | 0.59842445 |
| 92 | RET | 0.59273875 |
| 93 | MATK | 0.58562194 |
| 94 | TNK2 | 0.56424792 |
| 95 | MAPK12 | 0.54216192 |
| 96 | FYN | 0.53187447 |
| 97 | CDK9 | 0.52412945 |
| 98 | MAP3K11 | 0.52385334 |
| 99 | RPS6KB2 | 0.51849412 |
| 100 | MAPK15 | 0.51300094 |
| 101 | UHMK1 | 0.50816070 |
| 102 | DYRK3 | 0.50783010 |
| 103 | FER | 0.50298903 |
| 104 | JAK2 | 0.50102208 |
| 105 | PDK1 | 0.49561217 |
| 106 | CDK4 | 0.49026320 |
| 107 | CHUK | 0.48891127 |
| 108 | CDK6 | 0.47120554 |
| 109 | ILK | 0.46773939 |
| 110 | VRK2 | 0.45941711 |
| 111 | DAPK1 | 0.44608511 |
| 112 | MAP3K4 | 0.44146275 |
| 113 | MAP2K3 | 0.43029886 |
| 114 | NUAK1 | 0.41619491 |
| 115 | EPHB1 | 0.40768855 |
| 116 | PRKCD | 0.39717345 |
| 117 | MAP3K8 | 0.39549526 |
| 118 | KSR2 | 0.39312065 |
| 119 | PKN1 | 0.39258573 |
| 120 | MAP3K7 | 0.39101074 |
| 121 | VRK1 | 0.37257761 |
| 122 | RPS6KA6 | 0.36080724 |
| 123 | MAP3K9 | 0.35683728 |
| 124 | MARK3 | 0.35463993 |
| 125 | MAPKAPK2 | 0.34533264 |
| 126 | MAPK11 | 0.34092162 |
| 127 | BRSK1 | 0.33789557 |
| 128 | RPS6KC1 | 0.33554392 |
| 129 | RPS6KL1 | 0.33554392 |
| 130 | ABL1 | 0.33476066 |
| 131 | MAPK3 | 0.33231029 |
| 132 | PRKD2 | 0.31880882 |
| 133 | MAP2K6 | 0.31711774 |
| 134 | GRK7 | 0.31536335 |
| 135 | CDC42BPA | 0.28639455 |
| 136 | BRSK2 | 0.28304439 |
| 137 | MINK1 | 0.27731113 |
| 138 | SGK3 | 0.27714391 |
| 139 | IRAK2 | 0.27266354 |
| 140 | CSNK1A1L | 0.27077601 |
| 141 | LATS1 | 0.25631456 |
| 142 | PKN2 | 0.24461798 |
| 143 | STK11 | 0.24256030 |
| 144 | EGFR | 0.24091710 |
| 145 | CSNK1G3 | 0.23719817 |
| 146 | ZAP70 | 0.23440894 |
| 147 | STK4 | 0.23185185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 8.42864992 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.42647046 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.31921532 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.30589961 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.23622630 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.94951029 |
| 7 | Protein export_Homo sapiens_hsa03060 | 3.80091162 |
| 8 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.85617969 |
| 9 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.42148713 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.92174788 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.79118031 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.73571150 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.72629659 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.70965062 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.70744428 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.65378174 |
| 17 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.58639115 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.55508974 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.54155753 |
| 20 | Phagosome_Homo sapiens_hsa04145 | 1.53308885 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.48138502 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.45367102 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.37494001 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.28826331 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22609119 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11590969 |
| 27 | DNA replication_Homo sapiens_hsa03030 | 0.96619810 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95317698 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93963374 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 0.92744124 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92367159 |
| 32 | Measles_Homo sapiens_hsa05162 | 0.92333305 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91293159 |
| 34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90836942 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89582444 |
| 36 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.89406871 |
| 37 | Malaria_Homo sapiens_hsa05144 | 0.88489741 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.87930405 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87245978 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 0.82061960 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81664843 |
| 42 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80976801 |
| 43 | Base excision repair_Homo sapiens_hsa03410 | 0.80060320 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 0.79394185 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 0.77266844 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76826523 |
| 47 | Long-term potentiation_Homo sapiens_hsa04720 | 0.75781080 |
| 48 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70597463 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67046632 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65969424 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.64765819 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63643166 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62349594 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 0.62339840 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 0.61254512 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.61206856 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 0.60398181 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59413702 |
| 59 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.58668910 |
| 60 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.58161388 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57572710 |
| 62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56126107 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55888942 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55344981 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.55211102 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55010721 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.53803639 |
| 68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53710064 |
| 69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52901959 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.50474383 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50103024 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.49454226 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49421318 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48464458 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47774758 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47172398 |
| 77 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46436038 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46131930 |
| 79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45830415 |
| 80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.45265991 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44190838 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43423641 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42750555 |
| 84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42610028 |
| 85 | Alcoholism_Homo sapiens_hsa05034 | 0.42492253 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.41963517 |
| 87 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.40190200 |
| 88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38494699 |
| 89 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.38067773 |
| 90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.37490504 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 0.37306559 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37155727 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.37050731 |
| 94 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.36222918 |
| 95 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34760614 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.34716406 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.34440507 |
| 98 | Renin secretion_Homo sapiens_hsa04924 | 0.33743256 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33518603 |
| 100 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.33458436 |
| 101 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.31837410 |
| 102 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31066184 |
| 103 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.30744651 |
| 104 | Influenza A_Homo sapiens_hsa05164 | 0.30625459 |
| 105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30453714 |
| 106 | Shigellosis_Homo sapiens_hsa05131 | 0.30035333 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | 0.29600675 |
| 108 | Homologous recombination_Homo sapiens_hsa03440 | 0.28600387 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.28295337 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28032924 |
| 111 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.27988856 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.27980535 |
| 113 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.27100762 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26883412 |
| 115 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.26772890 |
| 116 | Phototransduction_Homo sapiens_hsa04744 | 0.26038037 |
| 117 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.25397991 |
| 118 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24074942 |
| 119 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.23528620 |
| 120 | Focal adhesion_Homo sapiens_hsa04510 | 0.22631812 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22488113 |
| 122 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.22196631 |
| 123 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.21656685 |
| 124 | Mismatch repair_Homo sapiens_hsa03430 | 0.21578206 |
| 125 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20784349 |
| 126 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.20362534 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19796931 |
| 128 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.18231715 |
| 129 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.18159822 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.17896869 |
| 131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.17769375 |
| 132 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17184717 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.17081567 |
| 134 | Sulfur relay system_Homo sapiens_hsa04122 | 0.15305583 |
| 135 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.14836621 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.14768810 |

